Access Bio (XKRX:950130) Short-Term Capital Lease Obligation : ₩4,632 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Short-Term Capital Lease Obligation?

Access Bio's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩4,632 Mil.

Access Bio's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩4,286 Mil) to Dec. 2023 (₩4,344 Mil) and increased from Dec. 2023 (₩4,344 Mil) to Mar. 2024 (₩4,632 Mil).

Access Bio's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩1,932 Mil) to Dec. 2022 (₩3,975 Mil) and increased from Dec. 2022 (₩3,975 Mil) to Dec. 2023 (₩4,344 Mil).

Access Bio Short-Term Capital Lease Obligation Historical Data

The historical data trend for Access Bio's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Short-Term Capital Lease Obligation Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

663.91

1,318.69

1,931.77

3,975.40

4,343.98

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															4,102.42	4,176.27	4,286.16	4,343.98	4,631.73

Access Bio Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Access Bio Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Access Bio's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines